文献速递先天性心脏病外科

双瓣化同种移植物可作为小口径右室流出道管道替代选择

Small-sized conduits in the right ventricular outflow tract in young children: bicuspidalized homografts are a good alternative to standard conduits.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

该回顾性研究分析了93例≤20 mm的右室流出道管道,比较双瓣化同种移植物与其他小口径管道的耐久性。中位随访7.6年显示,肺动脉同种移植物耐久性最佳,双瓣化同种移植物中期效果优于异种移植物。

要点

  • 肺动脉同种移植物仍是幼童右室流出道管道最耐久选择。
  • 无小口径肺动脉同种移植物时,双瓣化同种移植物中期优于异种移植物。
  • 较小管道尺寸、异位位置和异种移植物增加结构瓣膜退化风险。

核心结论

  • 合适尺寸的肺动脉同种移植物是幼童右室流出道管道最耐久选项,双瓣化同种移植物可作为有效替代且中期优于异种移植物。

研究设计与样本

  • 回顾性分析23年间植入的93例≤20 mm管道,包括40例肺动脉同种移植物、12例主动脉同种移植物、17例双瓣化同种移植物和24例异种移植物。

主要发现

  • 随访7.6±5.9年,住院生存率89%,5年和10年免于移植物取出率分别为83±5%和52±6%。
  • 5年和10年免于结构瓣膜退化率分别为79±5%和47±6%;10年时肺动脉同种移植物68±8%、双瓣化同种移植物42±16%、主动脉同种移植物31±15%、异种移植物20±9%(log rank P < 0.001)。
  • 多变量分析显示较小管道尺寸(HR 0.79,95%CI 0.67-0.94;P < 0.008)、异位位置(HR 2.71,95%CI 1.33-5.50;P = 0.006)和异种移植物(对比非双瓣化肺动脉同种移植物,HR 4.90,95%CI 2.23-10.76;P < 0.001)增加结构瓣膜退化风险。

临床怎么用

  • 幼童右室流出道重建优先选用合适尺寸的肺动脉同种移植物。
  • 小口径肺动脉同种移植物短缺时,可考虑双瓣化同种移植物而非异种移植物。
  • 避免使用异种移植物和异位位置以降低结构瓣膜退化风险。

局限性

  • 回顾性设计,样本量93例,随访时间不均,可能影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Downsizing a homograft (HG) through bicuspidalization has been used for more than 2 decades to overcome the shortage of small-sized conduits for reconstruction of the right ventricular outflow tract (RVOT) in young children. Our goal was to investigate the durability of bicuspidalized HGs compared with other small HGs. METHODS: A retrospective analysis of 93 conduits ≤20 mm, implanted over 23 years, was performed. The end-points were survival, structural valve degeneration and conduit replacement. The conduits comprised 40 pulmonary HGs, 12 aortic HGs, 17 bicuspidalized HGs and 24 xenografts. RESULTS: The median age, mean conduit diameter and z-value at implantation were 1.4 (interquartile range 0.3-3) years, 16.5 ± 2.7 mm and 2.8 ± 1.3, respectively. Valve position was heterotopic in 59 patients and orthotopic in 34 patients. At a mean follow-up period of 7.6 ± 5.9 years, the hospital survival rate was 89%. Freedom from explant at 5 and 10 years was 83 ± 5% and 52 ± 6%, respectively. Freedom from structural valve degeneration was 79 ± 5% at 5 years and 47 ± 6% at 10 years [68 ± 8% for pulmonary HG, 42 ± 16% for bicuspidalized HG, 31 ± 15% for aortic HG and 20 ± 9% for xenografts (log rank P < 0.001)]. Multivariable analysis indicated an increased risk for structural valve degeneration with smaller conduit size (hazard ratio 0.79, 95% confidence interval 0.67-0.94; P < 0.008), extra-anatomic position (hazard ratio 2.71, 95% confidence interval 1.33-5.50; P = 0.006) and the use of xenografts compared with non-downsized pulmonary HGs (hazard ratio 4.90, 95% confidence interval 2.23-10.76; P < 0.001). CONCLUSIONS: Appropriately sized pulmonary HGs remain the most durable option for a right ventricular outflow tract conduit in young children. However, when a small pulmonary HG is unavailable, bicuspidalization offers a valid alternative, preferable to xenograft conduits, at mid-term follow-up.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. François K, De Groote K, Vandekerckhove K, et al. Small-sized conduits in the right ventricular outflow tract in young children: bicuspidalized homografts are a good alternative to standard conduits. Eur J Cardiothorac Surg. 2018. PMID: 29029050. doi:10.1093/ejcts/ezx354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。